Poster: Bridging the Phenotype-Proteome Gap: A Multi-Modal AI Framework for analysis of Cell Painting images

Topic:

Format:

Bridging the Phenotype-Proteome Gap: A Multi-Modal AI Framework for analysis of Cell Painting images

About the poster

Cell Painting assay captures a vast range of morphological information. However, translating these visual phenotypes into biological insight remains a challenge. This study investigates the capacity of AI architectures to reconstruct proteomic profiles directly from morphological features.

We developed a multi-modal AI framework for proteomic profile prediction by integrating Cell Painting images with corresponding mass spectrometry data from cells treated with ~2000 reference compounds. We compared CellProfiler features against various Deep Learning  embeddings: Masked Autoencoder (MAE), self-distillation with no labels (DINO), and CLOOME. We focused on MAE with a ViT-B/8/224 backbone and optimized the model for microscopic images through high masking ratios and Fourier domain reconstruction loss. Using a Multilayer Perceptron (MLP) and nested cross-validation, we evaluated the models on two primary tasks: the classification of protein up/down regulation and the regression of normalized protein abundance.

Our findings demonstrate that classifying protein expression regulation is more robust than direct abundance regression. A substantial fraction of investigated proteins was predicted with high accuracy, with performance scaling in response to compound-induced perturbations. In a focused analysis of chemical treatments, the system successfully identified a large proportion of regulated proteins, showing strong dose-dependency for top-performing markers.

Results suggest a latent but measurable correspondence between cellular morphology and proteomic states. While challenges remain in achieving high-resolution reconstruction for all protein classes, we show that phenotypic profiling can serve as a proxy for capturing broader biological shifts, offering a potential bridge between morphological changes and proteomics cell state to support drug discovery processes.

You might be also interested in:

Biomedical knowledge graph connecting drug discovery data, disease biology, targets and indications to support target prioritization and indication expansion
Knowledge Graphs in Drug Discovery: Bringing Context to Internal Data Assets
Molecular structure representing AI-supported antibody design for blood-brain barrier research
How BBB-Penetrating Antibodies Cross the Blood-Brain Barrier
Life sciences conference takeaways 2026 - AACR, PEGS Boston, SLAS Europe, and Bio-IT World summary on AI in drug discovery
What 4 Life Sciences Conferences Revealed About AI in Drug Discovery
Life sciences professional using a tablet in front of digital data infrastructure screens
Scaling AI in Life Sciences: Why Data Infrastructure Determines Success

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!